Nifty
Sensex
:
:
24334.55
77656.09
115.50 (0.48%)
286.98 (0.37%)

Pharmaceuticals & Drugs - Global

Rating :
68/99

BSE: 500420 | NSE: TORNTPHARM

4932.00
25-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  4895
  •  4932
  •  4855.5
  •  4886.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  214851
  •  1050141480.5
  •  5250
  •  3480.6

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,87,140.99
  • 84.77
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,00,774.03
  • 0.77%
  • 20.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.31%
  • 0.29%
  • 5.04%
  • FII
  • DII
  • Others
  • 15.44%
  • 7.24%
  • 3.68%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.17
  • 10.44
  • 9.23

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.25
  • 12.46
  • 5.39

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.77
  • 22.72
  • 9.31

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 57.89
  • 60.36
  • 60.39

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.19
  • 12.03
  • 14.44

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 24.15
  • 27.17
  • 31.26

Earnings Forecasts:

(Updated: 22-08-2026)
Description
2026
2027
2028
2029
Adj EPS
78
-4
18.14
70.58
P/E Ratio
62.65
-1221.63
269.38
69.23
Revenue
61.76
47.32
40.58
13431.5
EBITDA
18094.5
20363.9
22350.8
4392.04
Net Income
5921.37
6896.26
7776.78
2395.72
ROA
2625.1
3475.73
4102.14
14.24
P/B Ratio
0.40
0.57
0.77
18.12
ROE
13.08
10.84
9.56
28.31
FCFF
24.77
26.72
26.48
2008.94
FCFF Yield
4033.95
5359.71
7527.45
1.12
Net Debt
2.24
2.98
4.18
6416.89
BVPS
12096
8527.63
6306.28
269.65

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
4,921.00
3,178.00
54.85%
4,197.00
2,959.00
41.84%
3,303.00
2,809.00
17.59%
3,302.00
2,889.00
14.30%
Expenses
3,257.00
2,146.00
51.77%
2,841.00
1,995.00
42.41%
2,215.00
1,895.00
16.89%
2,219.00
1,950.00
13.79%
EBITDA
1,664.00
1,032.00
61.24%
1,356.00
964.00
40.66%
1,088.00
914.00
19.04%
1,083.00
939.00
15.34%
EBIDTM
33.81%
32.47%
32.31%
32.58%
32.94%
32.54%
32.80%
32.50%
Other Income
-12.00
-37.00
-
-17.00
-18.00
-
-13.00
33.00
-
-27.00
-16.00
-
Interest
305.00
56.00
444.64%
236.00
56.00
321.43%
45.00
57.00
-21.05%
48.00
64.00
-25.00%
Depreciation
593.00
201.00
195.02%
508.00
201.00
152.74%
206.00
199.00
3.52%
204.00
198.00
3.03%
PBT
733.00
738.00
-0.68%
529.00
665.00
-20.45%
814.00
691.00
17.80%
791.00
661.00
19.67%
Tax
167.00
190.00
-12.11%
165.00
167.00
-1.20%
179.00
188.00
-4.79%
200.00
208.00
-3.85%
PAT
566.00
548.00
3.28%
364.00
498.00
-26.91%
635.00
503.00
26.24%
591.00
453.00
30.46%
PATM
11.50%
17.24%
8.67%
16.83%
19.22%
17.91%
17.90%
15.68%
EPS
16.72
16.19
3.27%
11.49
14.71
-21.89%
18.76
14.86
26.24%
17.46
13.38
30.49%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
15,723.00
13,979.73
11,516.09
10,727.84
9,620.15
8,508.04
8,004.57
7,939.31
7,672.80
5,949.83
5,815.69
Net Sales Growth
32.85%
21.39%
7.35%
11.51%
13.07%
6.29%
0.82%
3.47%
28.96%
2.31%
 
Cost Of Goods Sold
3,777.00
3,123.95
2,555.63
2,458.95
2,513.20
2,230.75
1,960.12
1,981.79
2,041.26
1,535.17
1,629.66
Gross Profit
11,946.00
10,855.78
8,960.46
8,268.89
7,106.95
6,277.29
6,044.45
5,957.52
5,631.54
4,414.66
4,186.03
GP Margin
75.98%
77.65%
77.81%
77.08%
73.88%
73.78%
75.51%
75.04%
73.40%
74.20%
71.98%
Total Expenditure
10,532.00
9,606.56
7,811.74
7,364.25
6,796.18
6,076.77
5,524.49
5,768.95
5,696.31
4,608.78
4,438.42
Power & Fuel Cost
-
160.83
137.34
145.20
155.28
144.19
122.94
128.19
132.46
118.77
107.98
% Of Sales
-
1.15%
1.19%
1.35%
1.61%
1.69%
1.54%
1.61%
1.73%
2.00%
1.86%
Employee Cost
-
2,670.85
2,203.37
1,984.40
1,677.69
1,526.45
1,439.62
1,429.04
1,403.79
1,135.25
993.41
% Of Sales
-
19.11%
19.13%
18.50%
17.44%
17.94%
17.98%
18.00%
18.30%
19.08%
17.08%
Manufacturing Exp.
-
743.67
594.29
570.58
570.79
591.13
550.92
544.11
558.84
457.58
502.16
% Of Sales
-
5.32%
5.16%
5.32%
5.93%
6.95%
6.88%
6.85%
7.28%
7.69%
8.63%
General & Admin Exp.
-
1,154.44
960.60
980.72
775.30
637.65
633.48
801.98
763.90
677.71
578.05
% Of Sales
-
8.26%
8.34%
9.14%
8.06%
7.49%
7.91%
10.10%
9.96%
11.39%
9.94%
Selling & Distn. Exp.
-
1,490.90
1,260.67
1,129.68
1,026.99
884.91
742.63
807.39
738.03
641.30
567.70
% Of Sales
-
10.66%
10.95%
10.53%
10.68%
10.40%
9.28%
10.17%
9.62%
10.78%
9.76%
Miscellaneous Exp.
-
261.92
99.84
94.72
76.93
61.69
74.78
76.45
58.03
43.00
567.70
% Of Sales
-
1.87%
0.87%
0.88%
0.80%
0.73%
0.93%
0.96%
0.76%
0.72%
1.02%
EBITDA
5,191.00
4,373.17
3,704.35
3,363.59
2,823.97
2,431.27
2,480.08
2,170.36
1,976.49
1,341.05
1,377.27
EBITDA Margin
33.02%
31.28%
32.17%
31.35%
29.35%
28.58%
30.98%
27.34%
25.76%
22.54%
23.68%
Other Income
-69.00
91.71
39.91
61.97
63.22
196.56
56.91
121.30
63.62
307.04
223.30
Interest
634.00
385.07
252.31
353.56
333.44
255.06
352.94
450.71
503.75
308.48
205.56
Depreciation
1,511.00
1,118.87
794.93
808.27
706.59
662.16
657.79
654.38
617.69
408.60
306.92
PBT
2,867.00
2,960.94
2,697.02
2,263.73
1,847.16
1,710.61
1,526.26
1,186.57
918.67
931.01
1,088.09
Tax
711.00
734.01
761.56
695.73
601.93
448.73
274.38
161.85
125.35
252.87
154.51
Tax Rate
24.80%
25.56%
28.49%
29.58%
32.59%
36.60%
17.98%
13.64%
22.32%
27.16%
14.20%
PAT
2,156.00
2,163.37
1,911.25
1,656.38
1,245.23
777.18
1,251.88
1,024.72
436.28
678.11
933.55
PAT before Minority Interest
2,181.00
2,138.18
1,911.25
1,656.38
1,245.23
777.18
1,251.88
1,024.72
436.31
678.14
933.58
Minority Interest
25.00
25.19
0.00
0.00
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
PAT Margin
13.71%
15.48%
16.60%
15.44%
12.94%
9.13%
15.64%
12.91%
5.69%
11.40%
16.05%
PAT Growth
7.69%
13.19%
15.39%
33.02%
60.22%
-37.92%
22.17%
134.88%
-35.66%
-27.36%
 
EPS
63.71
63.93
56.48
48.95
36.80
22.97
36.99
30.28
12.89
20.04
27.59

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
8,388.43
7,590.69
6,856.15
6,198.07
5,952.95
5,837.17
4,823.22
4,724.35
4,622.19
4,350.13
Share Capital
169.23
169.23
169.23
169.23
84.62
84.62
84.62
84.62
84.62
84.62
Total Reserves
8,219.20
7,421.46
6,686.92
6,028.84
5,868.33
5,752.55
4,738.60
4,639.73
4,537.57
4,265.51
Non-Current Liabilities
17,685.53
2,087.71
2,224.05
2,822.81
2,238.15
2,924.20
3,299.15
3,861.40
4,142.42
2,303.33
Secured Loans
11,651.17
1,191.75
1,603.78
2,496.22
2,123.22
2,941.07
3,302.29
3,909.81
4,105.31
2,229.57
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
1.56
3.11
6.15
11.26
Long Term Provisions
764.55
501.27
444.69
393.06
368.74
369.62
338.34
288.52
286.66
263.04
Current Liabilities
8,343.33
4,717.19
5,425.25
5,447.30
4,415.09
4,891.62
5,454.16
5,165.32
5,202.17
2,738.26
Trade Payables
2,357.61
1,820.02
2,089.32
1,678.80
1,674.44
2,066.81
2,048.81
2,096.74
2,048.24
1,749.32
Other Current Liabilities
2,451.48
1,143.50
1,130.15
1,578.41
1,365.10
1,635.36
1,860.80
1,641.26
1,151.68
687.14
Short Term Borrowings
2,914.57
1,249.97
1,637.71
1,765.07
923.04
704.40
1,090.85
934.11
1,625.60
0.00
Short Term Provisions
619.67
503.70
568.07
425.02
452.51
485.05
453.70
493.21
376.65
301.80
Total Liabilities
43,613.69
14,395.59
14,505.45
14,468.18
12,606.19
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
Net Block
33,178.08
7,946.90
8,138.11
8,121.45
6,422.65
7,064.63
7,533.12
7,747.71
7,854.68
3,688.44
Gross Block
40,405.45
14,041.34
13,484.57
12,811.62
10,728.19
10,511.53
10,334.13
9,935.43
9,449.48
4,909.80
Accumulated Depreciation
7,227.37
6,094.44
5,346.46
4,690.17
4,305.54
3,446.90
2,801.01
2,187.72
1,594.80
1,221.36
Non Current Assets
34,220.60
8,773.02
8,893.97
9,139.00
7,311.54
8,129.77
8,595.61
8,713.53
8,704.89
4,512.74
Capital Work in Progress
641.12
478.14
360.51
765.40
629.82
889.38
711.93
617.12
646.94
519.49
Non Current Investment
82.62
43.57
31.80
42.70
42.33
42.09
2.09
2.09
0.09
0.09
Long Term Loans & Adv.
281.33
294.29
349.34
181.04
166.55
96.84
222.19
150.58
130.96
182.32
Other Non Current Assets
24.35
10.12
14.21
28.41
50.19
36.83
126.28
196.03
72.22
122.40
Current Assets
9,391.89
5,622.57
5,611.48
5,313.72
5,164.99
5,521.50
4,979.06
5,037.53
5,262.32
4,879.38
Current Investments
865.74
112.21
141.04
156.09
183.98
139.05
0.02
351.35
492.27
803.55
Inventories
3,138.19
2,541.25
2,279.07
2,229.64
2,462.32
2,681.20
2,148.22
1,935.15
1,966.30
1,559.15
Sundry Debtors
3,030.86
1,866.45
1,844.30
1,943.82
1,632.48
1,523.37
1,649.34
1,435.71
1,253.45
950.89
Cash & Bank
1,165.20
579.46
839.04
571.46
403.41
603.50
666.65
816.04
867.23
893.72
Other Current Assets
1,191.90
323.62
327.99
246.89
482.80
574.38
514.83
499.28
683.07
672.07
Short Term Loans & Adv.
787.63
199.58
180.04
165.82
151.18
63.41
73.48
93.46
95.39
82.62
Net Current Assets
1,048.56
905.38
186.23
-133.58
749.90
629.88
-475.10
-127.79
60.15
2,141.12
Total Assets
43,612.49
14,395.59
14,505.45
14,452.72
12,476.53
13,651.27
13,574.67
13,751.06
13,967.21
9,392.12

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
3,022.71
2,585.11
3,266.08
2,368.13
1,802.99
2,005.35
1,392.91
1,798.08
894.15
1,008.84
PBT
2,872.19
2,672.81
2,352.11
1,847.16
1,225.91
1,526.26
1,186.57
561.66
931.01
1,088.09
Adjustment
1,301.41
996.05
993.99
937.24
1,349.95
992.84
876.21
1,418.19
606.92
430.27
Changes in Working Capital
-341.97
-480.93
418.08
-18.20
-351.85
-338.25
-385.83
99.39
-360.16
-125.21
Cash after chg. in Working capital
3,831.63
3,187.93
3,764.18
2,766.20
2,224.01
2,180.85
1,676.95
2,079.24
1,177.77
1,393.15
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-808.92
-602.82
-498.10
-398.07
-421.02
-175.50
-284.04
-281.16
-283.62
-384.31
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-12,712.41
-540.05
-167.90
-2,415.31
-196.63
-449.42
198.61
-241.28
-4,706.95
-786.91
Net Fixed Assets
-553.42
-476.77
-161.25
-2,494.94
-29.00
-198.83
-378.80
-610.74
-4,245.22
-592.01
Net Investments
-12,649.61
-59.42
-102.10
6.43
-53.72
-179.03
351.33
138.83
310.79
-17.69
Others
490.62
-3.86
95.45
73.20
-113.91
-71.56
226.08
230.63
-772.52
-177.21
Cash from Financing Activity
10,150.60
-2,297.99
-2,779.64
77.36
-1,781.05
-1,650.79
-1,549.04
-1,314.45
3,417.39
-192.91
Net Cash Inflow / Outflow
460.90
-252.93
318.54
30.18
-174.69
-94.86
42.48
242.35
-395.41
29.02
Opening Cash & Equivalents
573.48
835.14
508.53
398.40
572.56
661.82
588.76
702.04
1,067.57
1,049.86
Closing Cash & Equivalent
1,117.20
573.48
835.14
508.53
398.40
572.56
661.82
940.06
702.04
1,067.57

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
247.84
224.27
202.57
183.13
175.87
172.45
284.99
279.15
273.11
257.04
ROA
7.37%
13.23%
11.43%
9.20%
5.92%
9.20%
7.50%
3.15%
5.81%
10.28%
ROE
26.76%
26.46%
25.38%
20.50%
13.18%
23.49%
21.47%
9.34%
15.12%
23.80%
ROCE
19.27%
27.32%
24.28%
20.32%
14.35%
17.62%
15.28%
9.75%
13.81%
20.36%
Fixed Asset Turnover
0.72
1.22
1.27
1.39
1.43
1.43
1.48
1.50
1.57
1.35
Receivable days
45.41
40.18
41.38
39.99
37.86
38.92
37.65
33.78
35.74
74.66
Inventory Days
52.67
52.20
49.26
52.47
61.71
59.24
49.84
49.01
57.16
90.90
Payable days
244.06
279.17
279.66
243.50
306.08
383.19
133.47
139.05
150.99
171.27
Cash Conversion Cycle
-145.98
-186.79
-189.03
-151.04
-206.50
-285.04
-45.98
-56.26
-58.09
-5.72
Total Debt/Equity
1.76
0.40
0.57
0.85
0.68
0.83
1.21
1.28
1.40
0.58
Interest Cover
8.46
11.59
7.65
6.54
5.81
5.32
3.63
2.11
4.02
6.29

News Update:


  • Torrent Pharma reports marginal rise in Q1 consolidated net profit
    31st Jul 2026, 10:08 AM

    Consolidated total income of the company has increased 56.29% at Rs 4,909 crore for Q1FY27

    Read More
  • Torrent Pharma - Quarterly Results
    31st Jul 2026, 00:00 AM

    Read More
  • Torrent Pharma’s consolidated net profit falls 22% in Q4
    25th May 2026, 12:21 PM

    The total consolidated income of the company has increased by 42.13% at Rs 4,180.00 crore for Q4FY26

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.